Vyndaqel Coupon & Prices
Complete a free online enrollment application to find out if you’re eligible to pay only $49 per month for your Vyndaqel medication with our help.Get Started Now
Secure: Your personal and medical information is safe with us
Convenient: Your medication is delivered straight to your door
Ongoing refills: Your medication is refilled automatically
Secure: Your personal and medical information is safe with us
Convenient: We manage the whole process and we’re here to assist you
Ongoing refills: We request your medication refills on your behalf
NiceRx works with your healthcare provider to help you access affordable medications directly from U.S. pharmaceutical companies.
How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Vyndaqel cost savings if eligible
With our assistance, you could access the Vyndaqel patient assistance program and obtain your medication for free. We only charge a flat monthly fee of $49 per medication for our services.
Am I eligible for Vyndaqel patient assistance?
We review each Vyndaqel enrollment application individually to determine if you are eligible. Each assistance program has its own eligibility criteria and the factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Vyndaqel patient assistance program?
Our process makes it as easy as possible to apply for the Vyndaqel patient assistance program. Begin by completing the enrollment application form on our website. Tell us about any medications that you are taking, including Vyndaqel, your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers who will supply the medication, so it is important to make sure this information is accurate and up to date.
We will review the information that you have provided to determine whether you are eligible for patient assistance. If we can pre-qualify you for assistance, NiceRx will handle the full enrollment process on your behalf. If you are approved by the pharmaceutical company, you will typically start receiving your medication in 6 – 8 weeks.
Is NiceRx a Vyndaqel coupons provider?
NiceRx is not a Vyndaqel coupon, Vyndaqel discount card, or Vyndaqel copay card provider. We do not offer Vyndaqel manufacturer coupons, Vyndaqel discounts, rebates, Vyndaqel savings cards, trial offers, or free Vyndaqel samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Can NiceRx help me if I have insurance?
NiceRx may be able to help you if:
- You have a high copay or coinsurance responsibility for Vyndaqel
- Your insurance company will not pay for your Vyndaqel prescription
- Your healthcare plan does not cover your medication
- You do not have insurance
Please apply online to find out if we can help you.
How much does Vyndaqel cost without insurance?
Without insurance, Vyndaqel costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Vyndaqel oral capsule meglumine 20 mg will cost around $19,600 for 120 capsules.
How much does Vyndaqel cost with insurance?
The copay for Vyndaqel will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Vyndaqel?
Vyndaqel is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Pfizer Inc. The FDA approval was based on data from the pivotal Phase 3 Transthyretin Amyloidosis Cardiomyopathy Clinical Trial (ATTR-ACT). The first global, double-blind, randomized, placebo-controlled clinical study to investigate a pharmacological therapy for the treatment of this disease. In ATTR-ACT, Vyndaqel significantly reduced the hierarchical combination of all-cause mortality and frequency of cardiovascular-related hospitalizations compared to placebo over a 30-month period. Also, individual components of the primary analysis showed a relative reduction in the risk of all-cause mortality and frequency of cardiovascular-related hospitalization.
Vyndaqel and Vyndamax are transthyretin stabilizers used for the treatment of the cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults, to reduce cardiovascular mortality and cardiovascular-related hospitalization.
Transthyretin amyloid cardiomyopathy is a rare disease, where unstable transthyretin tetramers dissociate and result in a buildup of abnormal deposits of misfolded proteins that aggregate into amyloid fibrils and deposit in the heart. This causes the heart muscle to become stiff, eventually resulting in heart failure.
What doses of Vyndaqel are available?
Vyndaqel is available in capsule form, in the following doses: Tafamidis meglumine 20 mg and tafamidis 61 mg.
The recommended dose is either Vyndaqel 80 mg orally once daily, or Vyndamax 61 mg orally once daily.
Always speak with your healthcare professional for medical advice or about any changes to your dose so they can monitor and evaluate your condition.
Vyndaqel active ingredients
Vyndaqel contains the active ingredient tafamidis, a selective stabilizer of transthyretin (TTR). Tafamidis binds to TTR at the thyroxine-binding site, stabilizing the tetramer.
Vyndaqel side effects
The most common side effects of Vyndaqel in clinical trials include:
- Cough, difficulty breathing, problems swallowing
- Faster heart rate, dizziness
- Hive, itching, swelling of eyes, face, lips, or tongue
- Abdominal pain, diarrhea
Your doctor will assess the benefits of using Vyndaqel against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Vyndaqel to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Vyndaqel drug interactions
Vyndaqel can interact with other medications. These include:
This list is not exhaustive and other prescription drugs may interact with Vyndaqel.
You should not use Vyndaqel if you:
- Are allergic to the active ingredient tafamidis meglumine
- Are allergic to any of the other ingredients in Vyndaqel
- Are pregnant or are planning to become pregnant – tafamidis may cause fetal harm when given to a pregnant woman
- Are breastfeeding or are planning to breastfeed
Talk to your doctor before using Vyndaqel if you:
- Are taking any of the medications that could interact with Vyndaqel
Vyndaqel is the trademark brand name for tafamidis meglumine manufactured by Pfizer Inc. A generic version of tafamidis meglumine is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Vyndaqel savings through NiceRx.
*Qualifying persons may obtain medications directly from patient assistance programs without any out-of-pocket cost (or for less than $49 per medication). However, our monthly flat rate of just $49 per medication spares you the hassle of tracking the different programs and filling out all the required paperwork for each program. Subject to medication availability and acceptance by the pharmaceutical companies. NiceRx is not responsible for any delays or rejection by the pharmaceutical companies.
Enrollees enjoy a full-service solution, as NiceRx assists them and their physicians with the entire process. We prepare all required documents for the physician to sign, help enrollees manage all prescription refills, monitor eligibility criteria, and maintain enrollment.
**If you do not receive medications because you were determined to be ineligible for the prescription assistance by the applicable pharmaceutical companies and you have a letter of denial, we will refund any fees you paid toward medications for which you did not qualify to receive prescription assistance (“Refund”).
To receive a refund, you must send the letter of denial to us by fax to 888-517-7444, or by e-mail to [email protected] within 30 days of your receipt of such letter. The Refund is your sole and exclusive remedy for any fees you may wish to dispute.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.